Appeals court reverses Novartis win over Regeneron in Eylea-Lucentis battle
Regeneron on Monday successfully flipped a lower court’s decision in a hotly-contested case against Novartis regarding the companies’ competing eye injections.
The US Court of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.